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To the Editor
There are few data on the prevalence of type 1 diabetes mellitus1,2 and no estimates for the 
entire US population. The National Health and Nutrition Examination Survey (NHANES) is 
a representative cross-sectional survey of the civilian, noninstitutionalized US population. 
Although NHANES does not explicitly collect information on type 1 diabetes mellitus, we 
estimated the prevalence based on age of diabetes diagnosis, the age of insulin initiation, and 
current use of insulin.3
The protocol for the 1999–2010 NHANES was approved by the National Center for Health 
Statistics of the Centers for Disease Control and Prevention Ethics Review Board. All 
participants gave written informed consent. After excluding 2955 infants for whom diabetes 
data were not collected and 75 children and adults who were missing diabetes data, 59,130 
participants remained in the analytic sample.4 We considered participants to have type 1 
diabetes mellitus if they started insulin within 1 year of diabetes diagnosis, were currently 
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using insulin and were diagnosed with diabetes under age 30 (definition 1) or under age 40 
(definition 2).
Data were analyzed using SUDAAN, version 10.0 (Research Triangle Institute, Research 
Triangle Park, NC), accounting for the complex sampling design used in NHANES. The 
prevalence of diabetes (by each definition) was calculated overall and by age, race/ethnicity, 
and sex. The sum of sample weights was used to estimate the total number of the US 
population with type 1 diabetes. We calculated the percentage of diagnosed diabetes and all 
diabetes (diagnosed diabetes, or hemoglobin A1c ≥6.5%, or fasting glucose ≥126 mg/dL) 
that was type 1.
The overall fractions (weighted number) with type 1 diabetes mellitus based on definitions 1 
and 2 were 2.6/1000 (740,000 people) and 3.4/1000 (970,000 people), respectively (Table). 
The proportions of diagnosed diabetes that were type 1 were 4.6% and 6.0%, respectively. 
The proportions of all diabetes that were type 1 were 3.6% and 4.8% for definitions 1 and 2, 
respectively. Prevalence of type 1 diabetes mellitus increased an average of 0.08% per 4 
years for both definitions during the 12-year period 1999–2010 (test for trend, P = 0.02 for 
definition 1 and 0.06 for definition 2).
In previous estimates, the SEARCH for Diabetes in Youth Study2 had identified a 
prevalence of 1.5/1000 (95% confidence interval [CI] = 1.5 to 1.6/1000) among youth under 
the age of 20—lower than our estimate of 2.4/1000 for this age group. The National Survey 
of Children’s Health found 3.2/1000 (95% CI = 2.6 to 3.7/1000) of children under the age of 
18 had diabetes, although diagnosis was based on self-report and included both type 1 and 
type 2 diabetes.1
Although type 1 diabetes mellitus may develop at any age,5 estimates of the prevalence or 
incidence in older adults are limited.6,7 By definition, our estimates missed cases starting 
after the age of 40, while including some younger people with type 2 diabetes who required 
insulin within a year of diagnosis. Using a higher age cutpoint for diabetes diagnosis in our 
study would likely result in an even greater misclassification of type 2 diabetes as type 1. 
When age of diagnosis was not included in the definition (ie, when we include everyone 
with diabetes who started taking insulin within 1 year of diagnosis), the prevalence was 
5.7/1000, representing an upper bound of prevalence. Ideally, diabetes status should be 
determined based on data collected at or before diagnosis, particularly data on diabetes 
autoantibodies.8
Our prevalence estimates of type 1 diabetes mellitus in the entire civilian 
noninstitutionalized US population (2.6/1000 for definition 1 and 3.4/1000 for definition 2) 
are reasonable given current available data. However, the limitations of these data highlight 
the need for more comprehensive national data collection, both to fully understand the 
burden of diabetes and to plan healthcare response.
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TABLE
Percentage of Participants with Type 1 Diabetes Mellitus Overall and by Age, Race/Ethnicity, and Sex, 
NHANES 1999–2010 (n = 59,130)
Definition 1 Definition 2
No. % (95% CI)   No. % (95% CI)   
Overalla 123 0.26 (0.20–0.33) 160 0.34 (0.27–0.43)
Current agea (years)
 1–19 51 0.24 (0.17–0.33) 51 0.24 (0.17–0.33)
 20–39 38 0.34 (0.22–0.49) 49 0.42 (0.30–0.57)
 40–59 27 0.31 (0.16–0.55) 47 0.49 (0.30–0.75)
 ≥60 7 0.08 (0.02–0.18) 13 0.12 (0.05–0.23)
Race/ethnicity
 Non-Hispanic white 65 0.30 (0.21–0.42) 77 0.37 (0.27–0.49)
 Non-Hispanic black 35 0.29 (0.19–0.44) 51 0.47 (0.32–0.66)
 All Hispanic 21 0.12 (0.06–0.23) 29 0.23 (0.12–0.38)
  Mexican–Americanb 16 0.11 (0.05–0.19) 22 0.18 (0.11–0.27)
Sexa
 Male 63 0.30 (0.21–0.42) 84 0.40 (0.29–0.54)
 Female 60 0.22 (0.14–0.32) 76 0.28 (0.19–0.39)
Definition 1: Previous diagnosis of diabetes before age 30 years, now taking insulin, started taking insulin within 1 year of diagnosis.
Definition 2: Previous diagnosis of diabetes before age 40 years, now taking insulin, started taking insulin within 1 year of diagnosis.
aAll participants including those who self-reported other races were included.
b
Insufficient numbers of individuals in other Hispanic groups were available.
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